Home › Research › TREM2 and immune genetics
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
Xiong D, Wang Y, You M.. Nature communications, 2020-10-08
Topic: Brain proteins, microglia and lab models
Plain-language summary
Identifying factors underlying resistance to immune checkpoint therapy (ICT) is still challenging. Most cancer patients do not respond to ICT and the availability of the predictive biomarkers is limited. Here, we re-analyze a publicly available single-cell RNA sequencing (scRNA-seq) dataset of melanoma samples of patients subjected to ICT and identify a subset of macrophages overexpressing TREM2 and a subset of gammadelta T cells that are both overrepresented in the non-responding tumors.
What this study adds
Evidence grade: Low
This study found that TREM2-high macrophages and gamma-delta T cells were more common in melanoma patients who did not respond to immune checkpoint therapy. It is about cancer immunotherapy and provides no information about treating, curing or preventing Alzheimer's.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xiong, D., Wang, Y., & You, M. (2020). A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response. Nature communications. https://doi.org/10.1038/s41467-020-18546-x
Vancouver
Xiong D, Wang Y, You M. A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response. Nature communications. 2020. doi:10.1038/s41467-020-18546-x. PMID: 33033253.
BibTeX
@article{xiong2020-33033253,
author = {Xiong, D. and Wang, Y. and You, M.},
title = {{A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response}},
journal = {Nature communications},
year = {2020},
doi = {10.1038/s41467-020-18546-x},
pmid = {33033253},
url = {https://doi.org/10.1038/s41467-020-18546-x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Most cancer patients do not respond to ICT and the availability of the predictive biomarkers is limited.
- Here, we re-analyze a publicly available single-cell RNA sequencing (scRNA-seq) dataset of melanoma samples of patients subjected to ICT and identify a subset of macrophages overexpressing TREM2 and a subset of gammadelta T cells that are both overrepresented in the non-responding tumors.
- In addition, the percentage of a B cell subset is significantly lower in the non-responders.
- The presence of these immune cell subtypes is corroborated in other publicly available scRNA-seq datasets.
Why it matters
This study found that TREM2-high macrophages and gamma-delta T cells were more common in melanoma patients who did not respond to immune checkpoint therapy. It is about cancer immunotherapy and provides no information about treating, curing or preventing Alzheimer's.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 52/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Nature communications) |
| Journal's citation record | 4 / 4 | Nature Communications: journal h-index 747 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 209 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 26.1 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 4 / 6 | Cited 10.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 3 / 4 | Cited 92 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Ming You: h-index 57 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Medical College of Wisconsin: institution h-index 747 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33033253) |
| Free to read | 2 / 2 | Free to read |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s41467-020-18546-x
- PubMed: 33033253
- Original source →
- Free full text: Nature Communications →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in TREM2 and immune genetics from nearby years
Also tagged “r47h”
363 studies in the library carry the topic tag “r47h”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 363 tagged studies.